Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cough
Interventions
DRUG

Susu Xiao'er Zhike Granules

Susu Xiao'er Zhike Granules 1 bag(7g granule per bag,contains 20.25 g crude herbs), twice a day for five days

DRUG

Extremely-low dose Susu Xiao'er Zhike Granules

Extremely-low dose Susu Xiao'er Zhike Granules 1 bag (7g granule per bag,contains 1.01 g crude herbs), twice a day for five days

Trial Locations (19)

300381

The First Teaching Hospital of Tianjin University of TCM, Tianjin

Unknown

Anhui Provincial Children's Hospital, Hefei

Jiangjin District Central Hospital of Chongqing, Chongqing

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou

Zunyi First People's Hospital, Zunyi

Xingtai People's Hospital, Xingtai

The First Affiliated Hospital of Henan University, Kaifeng

The First Affiliated Hospital of Nanyang Medical College, Nanyang

Sanmenxia Central Hospital, Sanmenxia

Zhengzhou First People's Hospital, Zhengzhou

Sinopharm Dongfeng General Hospital, Shiyan

The First Affiliated Hospital of Hunan University of Chinese Medicine, Changshang

Huai'an First People's Hospital, Huai'an

Wuxi Eighth People's Hospital, Wuxi

The Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji

The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang

Changzhi People's Hospital, Changzhi

The Affiliated Hospital of Chengdu University of Chinese Medicine, Chengdu

Tianjin Children's Hospital, Tianjin

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY